Japan Core Inflation Slips to Over FourYear Low Dampening Expectations for BOJ Rate Hike Hanois Fine Dining Scene Highlights Seven Restaurants at the Forefront of Culinary Innovation CPF LIFE vs SelfInvesting Financial Management Ability May Determine Retirement Strategy Citi Lifts Price Target on Marvell Technology Highlighting Potential Upside for Chipmaker Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment FO Analysis Assessing ABB Call Option and Delhivery Put Option Strategies WHLRL Q2 2024 Earnings Senior Subordinated Convertible Notes Report Highlights Core EPS CNQ Q1 2026 Earnings EPS Beats Estimates by 147 Amid Falling Oil Prices WisdomTree Inc WT Q1 2026 Earnings EPS Beats Estimates Amid Narrow Stock Decline UONEK Q1 2026 Earnings Reported Loss Amidst No Analyst Coverage BBNX Q1 2026 Earnings NarrowerThanExpected Loss Drives Slight Negative Reaction MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback SAGTEC GLOBAL LIMITED SAGT Sees 769 Surge Testing Key Resistance at 110 Essent Group ESNT Holds Near 6055 After Modest Decline Support and Resistance Levels in Focus Silicon Valley Acquisition Corp SVAQ Holds Steady at 995 Consolidation in the SPAC Sector Public Service Enterprise Group PEG Shows Modest Uptick Amid Utility Sector Stability AXIL Brands Inc AXIL Hovers Near Support Amid Modest Decline Republic Digital Acquisition Company RDAG Holds Steady at 1029 as SPAC Consolidates Near Trust Value AA Mission Acquisition Corp II YCY Holds Steady at 1016 SPAC Continues Trading Near Trust Value Perceptive Capital Solutions Corp PCSC Minor Dip as Stock Consolidates Near Resistance TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels San Juan Basin Royalty Trust SJT Edges Lower as Energy Sector Consolidates ProCap Acquisition Corp Warrant PCAPW Holds Steady Near Support as Trading Activity Remains Subdued Understanding IPOs A Comprehensive Guide to Initial Public Offerings SNES Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain Japer Therapeutics Warrants JSPRW Flat at Penny Level Amid Minimal Activity